| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Myozenin-1 is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MYOZ1 |
| Gene ID: |
58529 |
| Uniprot ID: |
MYOZ1_HUMAN |
| Specificity: |
This antibody detects endogenous levels of MYOZ1 at Human, Mouse |
| Immunogen: |
Synthesized peptide derived from human MYOZ1 |
| Function | Myozenins may serve as intracellular binding proteins involved in linking Z-disk proteins such as alpha-actinin, gamma-filamin, TCAP/telethonin, LDB3/ZASP and localizing calcineurin signaling to the sarcomere. Plays an important role in the modulation of calcineurin signaling. May play a role in myofibrillogenesis. |
| Protein Name | Myozenin-1Calsarcin-2Filamin- - Actinin- And Telethonin-Binding ProteinProtein Fatz |
| Cellular Localisation | NucleusCell ProjectionPseudopodiumLocalized To The Nucleus And Pseudopodia Of Undifferentiated Cells And Detected Throughout The Myotubes Of Differentiated CellsColocalizes With Actn2Flnc And Myot At The Z-Lines Of Skeletal Muscle |
| Alternative Antibody Names | Anti-Myozenin-1 antibodyAnti-Calsarcin-2 antibodyAnti-Filamin- - Actinin- And Telethonin-Binding Protein antibodyAnti-Protein Fatz antibodyAnti-MYOZ1 antibodyAnti-MYOZ antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
